Careers  |  Sign In  |  Register

Latest in Endocrinology

Reuters Health • The Doctor's Channel Daily Newscast

Evidence of rosiglitazone’s cardiac harm "overwhelming"

NEW YORK (Reuters Health) - Two reports today in two separate journals -- a meta-analysis and a large retrospective study -- provide more evidence linking the thiazolidinedione rosiglitazone to an increased risk of myocardial infarction (MI). The retrospective study also ties rosiglitazone therapy to an...

Reuters Health • The Doctor's Channel Daily Newscast

Growth hormone factor reduces abdominal fat in HIV patients

NEW YORK (Reuters Health) – The notable accumulation of visceral fat that occurs in some patients with HIV who are on antiretroviral drugs can be reduced substantially by treatment with a growth hormone releasing hormone analog, tesamorelin. Lipid parameters are improved, as are measures of body image,...

Reuters Health • The Doctor's Channel Daily Newscast

Calcium channel blocker improves cardioprotection in hypertensive diabetics

NEW YORK (Reuters Health) - For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular events than does the combination of an ACE inhibitor with a diuretic. That’s according to the...